← Back to Search

Mesenchymal Stem Cells

Autologous, Adipose derived Mesenchymal Stem Cells for Spinal Cord Injury (CELLTOP Trial)

Phase 1
Waitlist Available
Led By Wenchun Qu, MD, PhD
Research Sponsored by Allan Dietz, Ph.D.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 96 weeks
Awards & highlights

CELLTOP Trial Summary

This trial is testing whether it's safe to give patients with spinal cord injuries mesenchymal stem cells derived from fat tissue. All subjects will receive this experimental treatment, which is not approved by the FDA.

Eligible Conditions
  • Spinal Cord Injury
  • Paralysis

CELLTOP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 96 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 96 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acute Coryza
Secondary outcome measures
Change in Aspartate Aminotransferase (AST)
Change in Blood Urea Nitrogen (BUN)
Change in Carbon Dioxide
+18 more

CELLTOP Trial Design

1Treatment groups
Experimental Treatment
Group I: Phase IExperimental Treatment1 Intervention
Patients will receive a single dose of 100 million autologous, adipose derived mesenchymal stem cells. The cells are isolated from patient's adipose tissue and expanded for intrathecal delivery.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Autologous, Adipose derived Mesenchymal Stem Cells
2017
Completed Phase 1
~10

Find a Location

Who is running the clinical trial?

Allan Dietz, Ph.D.Lead Sponsor
Allan DietzLead Sponsor
Mohamad BydonLead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Adipose Stem Cells for Traumatic Spinal Cord Injury
Mohamad Bydon 2017. "Adipose Stem Cells for Traumatic Spinal Cord Injury". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03308565.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top